Nasdaq Stock Market · SYRE

Spyre Therapeutics, Inc. price

Price history, key statistics, and comparable assets for Spyre Therapeutics, Inc..

$104.91

+1.44% ($1.49)

USD cached quoteYahoo Finance

Historical prices

Price history

Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.

Price chart range

1Y daily closing price

$104.91

Up +592.02% over 1Y

Range low
$14.82
Range high
$104.94

Use the left and right arrow keys to inspect prices. On a touch screen, tap the chart to inspect the nearest point.

1Y daily closing-price chart, up 592.02 percent

Aug 8, 2025Aug 7, 2026

Point-in-time fields

Key statistics

Previous close
$103.42
Open
$106.01
Day range
$103.64 to $106.67
52-week range
$14.51 to $108.14
Volume
526.6K
Average volume
862.17K
Market cap
9.25B
P/E ratio (TTM)
Not available

Profile

About Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. trades on Nasdaq Stock Market under SYRE and is grouped under Health Technology. Figures marked unavailable are not estimated.

Contextual peers

SYRE questions

Spyre Therapeutics, Inc. questions

What is the SYRE stock price?

Spyre Therapeutics, Inc. (SYRE) had a cached quote of $104.91 as of 2026-08-07T20:00:00.000Z. Market prices move, so this is not an execution quote.

Where does Glide get SYRE stock data?

Glide uses Yahoo Finance market data. Quotes and daily history are cached with the original market timestamp, and visiting this page does not contact Yahoo Finance.

Can I access SYRE through Glide?

Glide does not list a tokenized SYRE product in its current asset registry. This market-data page does not imply that the stock is tradeable on Glide.

Risk and data disclosure

Read before using this data

Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.

View Yahoo Finance source record